Skip to main content

Publisher: Wiley-Blackwell

Volume 13, Number 12, 1 December 2011

Does intentional weight loss reduce cancer risk?
pp. 1063-1072(10)
Authors: Byers, T.; Sedjo, R. L.

Favourites:
ADD

Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
pp. 1073-1087(15)
Authors: Rensing, K. L.; Reuwer, A. Q.; Arsenault, B. J.; von der Thüsen, J. H.; Hoekstra, J. B. L.; Kastelein, J. J. P.; Twickler, Th. B.

Favourites:
ADD
Favourites:
ADD

Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide
pp. 1105-1113(9)
Authors: Mack, C. M.; Smith, P. A.; Athanacio, J. R.; Xu, K.; Wilson, J. K.; Reynolds, J. M.; Jodka, C. M.; Lu, M. G. W.; Parkes, D. G.

Favourites:
ADD

Tigerinin‐1R: a potent, non‐toxic insulin‐releasing peptide isolated from the skin of the Asian frog,
pp. 1114-1122(9)
Authors: Ojo, O. O.; Abdel‐Wahab, Y. H. A.; Flatt, P. R.; Mechkarska, M.; Conlon, J. M.

Favourites:
ADD

Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats
pp. 1123-1129(7)
Authors: Zhao, M.; Li, Y.; Wang, J.; Ebihara, K.; Rong, X.; Hosoda, K.; Tomita, T.; Nakao, K.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more